Dual inhibition of PI3K and mTOR in cancer therapy: Mechanisms, clinical potential, and future perspectives
- Tasneem Al Anta
- , Ola Al Shehadat
- , Jalal Taneera
- , Shereen M. Aleidi
- , Ahmad A. Abuhelwa
- , Karem H. Alzoubi
- , Mohammad H. Semreen
- , Waseem El-Huneidi
- , Eman Abu-Gharbieh
- , Yasser Bustanji
- University of Sharjah
- University of Jordan
- College of Pharmacy, Qatar University
Research output: Contribution to journal › Review article › peer-review